Richard Bagger

Develops cancer and immunology drugs

Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients

Provides health insurance services

Operates as a state government authority that operates and manages air, land, rail & sea transport infrastructure

Functions as a College/University

Chamber of Commerce

Operates as a nonprofit organization dedicated to funding research, education and support services for all blood cancers

Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients

The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024.